Trials / Completed
CompletedNCT01229917
Rhinovirus Study With Lactobacillus Rhamnosus GG
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Valio Ltd · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the symptom impact of probiotic Lactobacillus rhamnosus GG during rhinovirus infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fruit juice with Lactobacillus rhamnosus GG, version 1 | |
| OTHER | Fruit juice with Lactobacillus rhamnosus GG, version 2 | |
| OTHER | Standard fruit juice |
Timeline
- First posted
- 2010-10-28
- Last updated
- 2011-07-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01229917. Inclusion in this directory is not an endorsement.